Orser Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Occidental Petroleum
OXY
|
+$2.92M |
| 2 |
Cullen/Frost Bankers
CFR
|
+$2.76M |
| 3 |
Range Resources
RRC
|
+$1.56M |
| 4 |
Air Products & Chemicals
APD
|
+$1.18M |
| 5 |
Chevron
CVX
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Value ETF
VTV
|
+$872K |
| 2 |
Zoetis
ZTS
|
+$867K |
| 3 |
Adobe
ADBE
|
+$288K |
| 4 |
Mastercard
MA
|
+$128K |
| 5 |
Boeing
BA
|
+$128K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Healthcare | 16.36% |
| 3 | Financials | 12.93% |
| 4 | Consumer Staples | 8.82% |
| 5 | Consumer Discretionary | 7.95% |
Similar funds
Orser Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Orser Capital Management held 47 positions worth $69.3M, up 23% from $56.3M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Orser Capital Management deployed $9.65M of net new capital in Q4 2022, opening 7 new positions and adding to 5 existing holdings. Its largest new stake was Occidental Petroleum: 42,900 shares worth $2.7M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Value ETF, an estimated $872K trimmed.
- Orser Capital Management's largest Q4 2022 buy was Occidental Petroleum: 42,900 shares worth $2.7M.
- Orser Capital Management added most to Cullen/Frost Bankers in Q4 2022, an estimated $2.76M increase.
- Orser Capital Management's biggest Q4 2022 reduction was Vanguard Morningstar Value ETF, cutting an estimated $872K.
- Orser Capital Management's ten largest holdings make up 52% of its $69.3M portfolio in Q4 2022.
- Orser Capital Management opened 7 new positions and closed 0 in Q4 2022.
- Orser Capital Management's portfolio value rose 23% quarter-over-quarter to $69.3M.
Based on Orser Capital Management's 13F filing for Q4 2022, filed 13 Jan 2023.